Immune system therapy shows wider promise against cancer

Therapy involves genetically modifying a patient’s own cells to help them recognize and attack cancer

In this Dec. 11, 2017 photo provided by Anna Carlstrand, her husband, Richard, receives the first of 20 Keytruda infusions at Memorial Sloan Kettering Cancer Center in New York. Carlstrand, 76, of Long Key, Florida, underwent the immunotherapy treatment for mesothelioma, an aggressive cancer of the lining of the lungs, and is now in remission. Results on his and other cases were discussed Sunday, March 31, 2019, at an American Association for Cancer Research conference in Atlanta. (Anna Carlstrand via AP)

A treatment that helps the immune system fight deadly blood cancers is showing early signs of promise against some solid tumors, giving hope that this approach might be extended to more common cancers in the future.

The treatment, called CAR-T therapy, involves genetically modifying some of a patient’s own cells to help them recognize and attack cancer. Richard Carlstrand of Long Key, Florida, had it more than a year ago for mesothelioma, an aggressive cancer of the lining of the lungs.

READ MORE: Why cancer is deadlier than fire for firefighters in B.C.

“We were going into unknown territories” to try this, he said, but now he shows no sign of cancer and “I couldn’t be happier.”

Results on his and other cases were discussed Sunday at an American Association for Cancer Research conference in Atlanta.

The first CAR-T therapies were approved in 2017 for some leukemias and lymphomas. After being altered in the lab, the modified immune system cells are returned to the patient through an IV, which puts them right where the cancer is — in the blood.

But that approach doesn’t work well if the cells have to travel far through the bloodstream to get to tumors in the lung, breast, colon, or other places.

“Solid tumors are notorious for not letting the immune cells enter,” and not enough may make it in to have an effect, said Dr. Prasad Adusumilli of Memorial Sloan Kettering Cancer Center in New York.

A bigger worry is that the proteins on solid tumour cells that these therapies target also are found on normal cells at lower levels, so the therapy might harm them, too.

Adusumilli helped design a new CAR-T to try to avoid these problems and tested it on 19 patients with mesothelioma and two others with lung and breast cancer, respectively, that had spread to the chest lining. About 150,000 patients in the U.S. each year face this situation.

The modified cells were injected directly into the chest where the tumors were. A genetic safety switch was added so a medicine could be given to destroy the cells if they caused harm.

After the therapy, one patient was able to have surgery and radiation, and is doing well 20 months later with no further treatment. Fifteen others were well enough to start on a drug that boosts the immune system in a different way.

Eleven of the 15 have been studied long enough to report results. Two had signs of cancer disappear for about a year, although one later relapsed. Six saw their tumors shrink. Three saw their cancer worsen.

There were no severe side effects although some patients had temporarily low blood counts and fatigue.

Grants from the federal government and foundations paid for the work and a larger study is planned. Sloan Kettering has licensed the treatment to Atara Biotherapeutics and may get payments from it, as may Adusumilli.

A second study tested a different CAR-T therapy in 10 children and adults with advanced sarcomas — cancers that originate in various soft tissues or bones. Unlike other CAR-Ts that are usually given just once, this one was given multiple times, up to 15 in one patient’s case, if there were signs it was helping.

“From a single blood draw we make a large amount of the CAR-T cells and then we freeze them” and give them through an IV as needed, said Dr. Shoba Navai of Baylor College of Medicine in Houston.

Two of the 10 patients had all signs of cancer disappear, one for 17 months and the other for nearly three years, so far. Three others had their disease stabilized. Five worsened despite treatment.

Side effects were similar to the other study. The therapy seems safe “and we have early signs that this treatment approach may help,” Navai said.

Several foundations and charities paid for the work.

“These studies are showing there may be a path forward in solid tumors” with CAR-T therapies, said Dr. Louis Weiner, director of the Georgetown Lombardi Comprehensive Cancer Center and one of the conference leaders. It may hold promise for some cancers of the stomach, breast, colon, lung and other areas, he said.

Cost is a big issue — current CAR-T therapies are around $400,000 but can be made for far less than that in research centres. Doctors say they hope the cost will come down as more come on the market and find their way to wider use.

Marilynn Marchione, The Associated Press

Like us on Facebook and follow us on Twitter

Just Posted

Free Clark’s Nutcracker presentation Wednesday at Scout Island

Speakers for the event are Randy Moody and Ken Wright

BC Wildfire Service fighting new fire near Comstock Lake

The fire is 76 hectares in size and currently out of control

Moleschi, Canada, claim Kitakyushu Sevens title as 2020 Olympics draw near

Canada now sits in second place in the overall series standings with 66 points

COLUMNS: Set enforceable standards

We all wish Mayor Walt Cobb a speedy recovery

SLIDESHOW: 3rd annual Realm of Toys Easter Festival in Williams Lake a great success

From a petting zoo to a bouncy castle and animal balloons, lakecity children loved the event

What’s age got to do with it? B.C. couple with 45-year gap talks happy marriage

An Armstrong couple that has 45-year age gap began turning heads after being featured on show Extreme Love.

B.C. men challenge constitutionality of Canada’s secret no-fly list

Parvkar Singh Dulai says he received a “denial of boarding” notification under the no-fly program last May 17

Murder on B.C. property didn’t need to be disclosed before sale, court rules

Buyer had tried to break contract after learning a man with ties to crime had been murdered there

B.C.’s largest Vaisakhi festival target of threatening Facebook post: Surrey RCMP

Police say they are investigating the posts on Facebook, after local MLA forwarded screenshots

Pug life: B.C. town boasts waggish list of dog names

Freedom-of-information request lists most ‘pupular’ dog names registered in White Rock

VIDEO: Fish farming company launches $30-million vessel to treat salmon for sea lice in B.C. waters

Freshwater treatment an improvement but fish farms should be removed from sea, says conservationist

Singh says childhood abuse steeled him for scrutiny and stress of politics

He recounts the assaults for the first time in his book Love & Courage

Despite five extra weeks’ parental leave in Canada, dads still face stigma: survey

One reason people said dads don’t need leave is because they can just bond with their kids at weekend

Vintage bottles, magic cards, a 1969 Playboy: Quirky items found in historic B.C. buildings

Crews set aside some of the funkier pieces emerging from the construction rubble

Most Read